ITT Inc.
US ˙ NYSE ˙ US45073V1089

Introduction

This page provides a comprehensive analysis of the known insider trading history of Steven R Loranger. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Steven R Loranger has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:EW / Edwards Lifesciences Corporation Director 65,054
US:XYL / Xylem Inc. Director 13,818
US:FDX / FedEx Corporation Director 3,700
US:XLS / Exelis Director 30,450
US:ITT / ITT Inc. Chairman, President and CEO, Director 132,265
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Steven R Loranger. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ITT / ITT Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ITT / ITT Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ITT / ITT Inc. Insider Trades
Insider Sales ITT / ITT Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ITT / ITT Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2009-11-17 ITT LORANGER STEVEN R 47,862 53.3000 47,862 53.3000 2,551,045 730
2009-11-17 ITT LORANGER STEVEN R 8,925 53.0600 8,925 53.0600 473,560

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ITT / ITT Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Steven R Loranger as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-05-09 2025-05-09 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1,154 65,054 1.81
2025-05-09 2025-05-09 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 3,528 63,900 5.84
2025-02-14 2025-02-14 4 EW Edwards Lifesciences Corp
Common Stock
S - Sale -5,739 60,372 -8.68 76.42 -438,576 4,613,640
2025-02-14 2025-02-14 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise 5,739 66,111 9.51 45.32 260,073 2,995,932
2024-05-09 2024-05-08 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 999 60,372 1.68
2024-05-09 2024-05-08 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 3,055 59,373 5.42
2023-05-22 2023-05-18 4 XYL Xylem Inc.
Common Stock
A - Award 1,580 13,818 12.91
2023-05-15 2023-05-12 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 898 56,318 1.62
2023-05-15 2023-05-12 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2,803 55,420 5.33
2022-05-16 2022-05-12 4 XYL Xylem Inc.
Common Stock
A - Award 1,812 12,238 17.38
2022-05-05 2022-05-04 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 737 52,617 1.42
2022-05-05 2022-05-04 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2,300 51,880 4.64
2022-02-07 2021-12-14 5 XYL Xylem Inc.
Common Stock
G - Gift -12,491 46,407 -21.21
2021-05-13 2021-05-12 4 XYL Xylem Inc.
Common Stock
A - Award 1,328 22,293 6.33
2021-05-07 2021-05-05 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 3,270 3,270
2021-05-07 2021-05-05 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2,615 49,580 5.57
2021-02-01 2020-11-18 5 XYL Xylem Inc.
Common Stock
G - Gift -13,545 58,898 -18.70
2020-11-17 2020-11-16 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
M - Exercise -19,797 0 -100.00
2020-11-17 2020-11-16 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise 19,797 46,965 72.87 35.20 696,789 1,653,013
2020-09-15 2020-09-11 4 XYL Xylem Inc.
Common Stock
S - Sale -18,388 9,098 -66.90 83.95 -1,543,623 763,753
2020-05-14 2020-05-13 4 XYL Xylem Inc.
Common Stock
A - Award 2,577 20,965 14.01
2020-05-11 2020-05-08 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 1,378 1,378
2020-05-11 2020-05-08 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1,101 9,056 13.84
2020-02-14 2020-02-12 4 XYL Xylem Inc.
Common Stock
S - Sale -30,000 72,443 -29.28 88.61 -2,658,378 6,419,363
2020-02-13 2019-11-14 5 XYL Xylem Inc.
Common Stock
G - Gift -18,475 102,443 -15.28
2019-05-17 2019-05-15 4 XYL Xylem Inc.
Common Stock
A - Award 1,831 24,909 7.93
2019-05-13 2019-05-09 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 414 7,955 5.49
2019-05-13 2019-05-09 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1,323 7,541 21.28
2019-03-18 2019-03-15 4 XYL Xylem Inc.
Common Stock
S - Sale -10,000 120,918 -7.64 76.99 -769,917 9,309,682
2018-05-22 2018-05-18 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 1,913 1,913
2018-05-22 2018-05-18 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1,655 6,218 36.27
2018-05-10 2018-05-09 4 XYL Xylem Inc.
Common Stock
A - Award 1,947 23,078 9.21
2017-12-20 2017-12-20 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -12,120 0 -100.00
2017-12-20 2017-12-20 4 XYL Xylem Inc.
Common Stock
S - Sale -12,120 21,131 -36.45 68.14 -825,840 1,439,837
2017-12-20 2017-12-20 4 XYL Xylem Inc.
Common Stock
M - Exercise X 12,120 33,251 57.36 32.38 392,446 1,076,667
2017-12-20 2017-12-19 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -5,019 12,120 -29.28
2017-12-20 2017-12-19 4 XYL Xylem Inc.
Common Stock
S - Sale -5,019 21,131 -19.19 68.00 -341,314 1,437,001
2017-12-20 2017-12-19 4 XYL Xylem Inc.
Common Stock
M - Exercise X 5,019 26,150 23.75 32.38 162,515 846,737
2017-12-19 2017-12-18 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -47,712 17,139 -73.57
2017-12-19 2017-12-18 4 XYL Xylem Inc.
Common Stock
S - Sale -47,712 21,131 -69.31 68.10 -3,248,958 1,438,920
2017-12-19 2017-12-18 4 XYL Xylem Inc.
Common Stock
M - Exercise X 47,712 68,843 225.79 32.38 1,544,915 2,229,136
2017-12-15 2017-12-13 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -200 64,851 -0.31
2017-12-15 2017-12-13 4 XYL Xylem Inc.
Common Stock
S - Sale -200 21,131 -0.94 68.02 -13,604 1,437,331
2017-12-15 2017-12-13 4 XYL Xylem Inc.
Common Stock
M - Exercise X 200 21,331 0.95 32.38 6,476 690,698
2017-12-13 2017-12-11 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -196 65,051 -0.30
2017-12-13 2017-12-11 4 XYL Xylem Inc.
Common Stock
S - Sale -196 21,131 -0.92 68.23 -13,373 1,441,768
2017-12-13 2017-12-11 4 XYL Xylem Inc.
Common Stock
M - Exercise X 196 21,327 0.93 32.38 6,346 690,568
2017-11-08 2017-11-06 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -50,000 65,247 -43.39
2017-11-08 2017-11-06 4 XYL Xylem Inc.
Common Stock
S - Sale -37,700 21,131 -64.08 66.25 -2,497,625 1,399,929
2017-11-08 2017-11-06 4 XYL Xylem Inc.
Common Stock
M - Exercise 50,000 58,831 566.19 32.38 1,619,000 1,904,948
2017-06-30 2017-06-29 4 XYL Xylem Inc.
Stock option (right to buy)
M - Exercise -9,933 0 -100.00
2017-06-30 2017-06-29 4 XYL Xylem Inc.
Common Stock
S - Sale X -9,933 8,831 -52.94 55.05 -546,802 486,138
2017-06-30 2017-06-29 4 XYL Xylem Inc.
Common Stock
M - Exercise X 9,933 18,764 112.48 30.03 298,283 563,474
2017-06-30 2017-06-28 4 XYL Xylem Inc.
Stock Option (right to buy)
M - Exercise -56,199 9,933 -84.98
2017-06-30 2017-06-28 4 XYL Xylem Inc.
Common Stock
S - Sale X -56,199 8,831 -86.42 55.00 -3,091,057 485,723
2017-06-30 2017-06-28 4 XYL Xylem Inc.
Common Stock
M - Exercise X 56,199 65,030 636.38 30.03 1,687,628 1,952,818
2017-05-15 2017-05-12 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 588 4,563 14.79
2017-05-15 2017-05-12 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2,034 3,975 104.79
2017-05-11 2017-05-10 4 XYL Xylem Inc.
Common Stock
A - Award 2,743 8,831 45.06
2016-08-12 2016-08-11 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -28,732 66,132 -30.29
2016-08-12 2016-08-11 4 XYL Xylem Inc.
Common Stock
S - Sale X -28,732 6,088 -82.52 48.13 -1,382,871 293,015
2016-08-12 2016-08-11 4 XYL Xylem Inc.
Common Stock
M - Exercise X 28,732 34,820 471.94 30.03 862,822 1,045,645
2016-08-12 2016-08-10 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -5,155 94,864 -5.15
2016-08-12 2016-08-10 4 XYL Xylem Inc.
Common Stock
S - Sale X -5,155 6,088 -45.85 48.00 -247,440 292,224
2016-08-12 2016-08-10 4 XYL Xylem Inc.
Common Stock
M - Exercise X 5,155 11,243 84.67 30.03 154,805 337,627
2016-08-01 2016-07-28 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -32,246 100,019 -24.38
2016-08-01 2016-07-28 4 XYL Xylem Inc.
Common Stock
S - Sale X -32,246 6,088 -84.12 48.01 -1,548,130 292,285
2016-08-01 2016-07-28 4 XYL Xylem Inc.
Common Stock
M - Exercise X 32,246 38,334 529.66 30.03 968,347 1,151,170
2016-06-02 2016-06-01 4 XYL Xylem Inc.
Common Stock
S - Sale -50,000 77,118 -39.33 44.52 -2,226,000 3,433,293
2016-05-31 2016-05-27 4 XYL Xylem Inc.
Common Stock
S - Sale -50,000 127,118 -28.23 44.67 -2,233,675 5,678,806
2016-05-26 2016-05-24 4 EW Edwards Lifesciences Corp
Common Stock
P - Purchase 5,000 5,000 101.07 505,344 505,344
2016-05-17 2016-05-13 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1,941 1,941
2016-05-16 2016-05-12 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 6,599 6,599
2016-05-12 2016-05-11 4 XYL Xylem Inc.
Common Stock
A - Award 2,799 12,588 28.59
2015-11-06 2015-11-05 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -100,000 0 -100.00
2015-11-06 2015-11-05 4 XYL Xylem Inc.
Common Stock
S - Sale -100,000 9,789 -91.08 36.73 -3,672,910 359,541
2015-11-06 2015-11-05 4 XYL Xylem Inc.
Common Stock
M - Exercise 100,000 109,789 1,021.55 18.63 1,863,300 2,045,698
2015-11-06 2015-11-04 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -65,690 100,000 -39.65
2015-11-06 2015-11-04 4 XYL Xylem Inc.
Common Stock
S - Sale -65,690 9,789 -87.03 36.62 -2,405,450 358,456
2015-11-06 2015-11-04 4 XYL Xylem Inc.
Common Stock
M - Exercise 65,690 75,479 671.06 18.63 1,224,002 1,406,400
2015-05-13 2015-05-12 4 XYL Xylem Inc.
Common Stock
A - Award 3,289 9,789 50.60
2014-11-13 2014-11-12 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -100,000 0 -100.00
2014-11-13 2014-11-12 4 XYL Xylem Inc.
Common Stock
S - Sale -100,000 6,500 -93.90 37.51 -3,750,730 243,797
2014-11-13 2014-11-12 4 XYL Xylem Inc.
Common Stock
M - Exercise 100,000 106,500 1,538.46 29.80 2,980,500 3,174,232
2014-05-07 2014-05-06 4 XYL Xylem Inc.
Common Stock
A - Award 3,249 6,500 99.94
2014-01-17 2014-01-15 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -89,235 0 -100.00
2014-01-17 2014-01-15 4 XYL Xylem Inc.
Common Stock
S - Sale X -89,235 3,251 -96.48 36.08 -3,219,349 117,287
2014-01-17 2014-01-15 4 XYL Xylem Inc.
Common Stock
M - Exercise X 89,235 92,486 2,744.85 32.56 2,905,117 3,010,956
2013-09-24 2013-09-23 4 FDX FEDEX CORP
Stock Option (Right to Buy)
A - Award 3,700 3,700
2013-05-08 2013-05-07 4 XYL Xylem Inc.
Common Stock
A - Award 3,251 33,452 10.76
2013-01-15 2012-12-24 4 XLS Exelis Inc.
Common Stock
J - Other -111,224 30,450 -78.51
2013-01-15 2012-12-21 4 XLS Exelis Inc.
Common Stock
J - Other -21,488 141,674 -13.17
2012-12-20 2012-12-19 4 XLS Exelis Inc.
Common Stock
S - Sale -317 0 -100.00 11.58 -3,671
2012-12-20 2012-12-18 4 XLS Exelis Inc.
Common Stock
J - Other -250,000 163,162 -60.51
2012-12-18 2012-10-19 4 XYL Xylem Inc.
Phantom Stock
J - Other -32 0 -100.00 24.22 -768
2012-12-18 2012-10-19 4 XLS Exelis Inc.
Phantom Stock
J - Other -32 0 -100.00 10.72 -348
2012-11-01 2012-10-26 4 XLS Exelis Inc.
Stock Option (Right to Buy)
M - Exercise -250,000 0 -100.00
2012-11-01 2012-10-26 4 XLS Exelis Inc.
Common Stock
M - Exercise 250,000 413,162 153.22 9.41 2,351,450 3,886,119
2012-09-28 2012-09-26 4 XYL Xylem Inc.
Common Stock
J - Other -356 0 -100.00 21.56 -7,665
2012-09-25 2012-09-24 4 FDX FEDEX CORP
Stock Option (Right to Buy)
A - Award 4,720 4,720
2012-09-18 2012-09-14 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -75,000 0 -100.00
2012-09-18 2012-09-14 4 XYL Xylem Inc.
Common Stock
S - Sale -72,300 158,694 -31.30 25.45 -1,840,122 4,038,953
2012-09-18 2012-09-14 4 XYL Xylem Inc.
Common Stock
M - Exercise 75,000 230,994 48.08 23.31 1,748,212 5,384,355
2012-09-14 2012-09-12 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -50,000 75,000 -40.00
2012-09-14 2012-09-12 4 XYL Xylem Inc.
Common Stock
S - Sale -48,300 155,994 -23.64 25.18 -1,216,204 3,927,960
2012-09-14 2012-09-12 4 XYL Xylem Inc.
Common Stock
M - Exercise 50,000 204,294 32.41 23.31 1,165,475 4,761,991
2012-09-11 2012-09-11 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -50,000 125,000 -28.57
2012-09-11 2012-09-11 4 XYL Xylem Inc.
Common Stock
S - Sale -48,600 154,294 -23.95 25.10 -1,220,006 3,873,242
2012-09-11 2012-09-11 4 XYL Xylem Inc.
Common Stock
M - Exercise 50,000 202,894 32.70 23.31 1,165,475 4,729,358
2012-09-11 2012-09-10 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -50,000 175,000 -22.22
2012-09-11 2012-09-10 4 XYL Xylem Inc.
Common Stock
S - Sale -48,750 152,894 -24.18 24.82 -1,209,921 3,794,661
2012-09-11 2012-09-10 4 XYL Xylem Inc.
Common Stock
M - Exercise 50,000 201,644 32.97 23.31 1,165,475 4,700,221
2012-09-11 2012-09-07 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -25,000 225,000 -10.00
2012-09-11 2012-09-07 4 XYL Xylem Inc.
Common Stock
S - Sale -24,500 151,644 -13.91 25.01 -612,836 3,793,178
2012-09-11 2012-09-07 4 XYL Xylem Inc.
Common Stock
M - Exercise 25,000 176,144 16.54 23.31 582,738 4,105,829
2012-05-14 2012-05-10 4 XYL Xylem Inc.
Common Stock
A - Award 3,443 151,144 2.33
2012-05-11 2012-05-09 4 XLS Exelis Inc.
Common Stock
A - Award 8,257 163,162 5.33
2012-05-03 2012-05-01 4 XYL Xylem Inc.
Phantom Stock
X - Other -8 31 -20.00 27.66 -217 870
2012-05-03 2012-05-01 4 XYL Xylem Inc.
Common Stock
J - Other -8 147,701 -0.01 27.66 -217 4,085,410
2012-05-03 2012-05-01 4 XYL Xylem Inc.
Common Stock
X - Other 8 147,709 0.01 27.66 217 4,085,627
2012-05-03 2012-05-01 4 XYL Xylem Inc.
Common Stock
F - Taxes -72,246 147,701 -32.85 27.95 -2,019,276 4,128,243
2012-05-03 2012-05-01 4 XLS Exelis Inc.
Phantom Stock
X - Other -8 32 -20.00 11.74 -93 373
2012-05-03 2012-05-01 4 XLS Exelis Inc.
Common Stock
J - Other -8 154,905 -0.01 11.74 -93 1,818,585
2012-05-03 2012-05-01 4 XLS Exelis Inc.
Common Stock
X - Other 8 154,913 0.01 11.74 93 1,818,678
2012-05-03 2012-05-01 4 XLS Exelis Inc.
Common Stock
F - Taxes -68,940 154,905 -30.80 11.72 -807,632 1,814,712
2012-03-07 2012-03-05 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -99,120 0 -100.00
2012-03-07 2012-02-09 4 XYL Xylem Inc.
Common Stock
S - Sale -99,120 234,417 -29.72 26.29 -2,605,786 6,162,635
2012-03-07 2012-02-09 4 XYL Xylem Inc.
Common Stock
M - Exercise 99,120 333,537 42.28 25.53 2,530,246 8,514,232
2012-03-07 2012-01-03 4 XYL Xylem Inc.
Common Stock
A - Award 545 234,417 0.23 25.14 13,701 5,893,243
2012-03-07 2012-03-07 4 XLS Exelis Inc.
Stock Option (Right to Buy)
M - Exercise -100,000 0 -100.00
2012-03-07 2012-03-07 4 XLS Exelis Inc.
Common Stock
S - Sale -100,000 222,681 -30.99 11.48 -1,148,350 2,557,157
2012-03-07 2012-03-07 4 XLS Exelis Inc.
Common Stock
M - Exercise 100,000 322,681 44.91 10.30 1,030,060 3,323,808
2012-03-07 2012-03-06 4 XLS Exelis Inc.
Stock Option (Right to Buy)
M - Exercise -99,120 100,000 -49.78
2012-03-07 2012-03-06 4 XLS Exelis Inc.
Common Stock
S - Sale -99,120 222,681 -30.80 11.16 -1,106,249 2,485,276
2012-03-07 2012-03-06 4 XLS Exelis Inc.
Common Stock
M - Exercise 99,120 321,801 44.51 10.30 1,020,995 3,314,743
2012-02-13 2012-02-09 4 XYL Xylem Inc.
Stock Option (Right to Buy)
M - Exercise -100,000 99,120 -50.22
2012-02-13 2012-02-09 4 XYL Xylem Inc.
Common Stock
S - Sale -100,000 233,872 -29.95 27.09 -2,709,430 6,336,598
2012-02-13 2012-02-09 4 XYL Xylem Inc.
Common Stock
M - Exercise 100,000 333,872 42.76 25.53 2,552,710 8,522,784
2012-02-13 2012-01-03 4 XYL Xylem Inc.
Phantom Stock
J - Other 0 39 0.40 25.14 4 984
2012-02-13 2011-11-01 4/A XYL Xylem Inc.
Phantom Stock
J - Other 39 39
2012-01-06 2011-11-01 4/A XYL Xylem Inc.
Phantom Stock
A - Award 39 39
2012-01-05 2012-01-03 4 XLS Exelis Inc.
Phantom Stock
A - Award 0 39 1.11 9.31 4 367
2012-01-05 2012-01-03 4 XLS Exelis Inc.
Common Stock
A - Award 1,502 237,654 0.64 9.31 13,984 2,212,559
2011-11-03 2011-11-01 4 XYL Xylem Inc.
Phantom Stock
A - Award 20 20
2011-11-03 2011-11-01 4 XYL Xylem Inc.
Stock Option (Right to Buy)
A - Award 115,247 115,247
2011-11-03 2011-11-01 4 XYL Xylem Inc.
Stock Option (Right to Buy)
A - Award 132,265 132,265
2011-11-03 2011-11-01 4 XYL Xylem Inc.
Stock Option (Right to Buy)
A - Award 165,690 165,690
2011-11-03 2011-11-01 4 XYL Xylem Inc.
Stock Option (Right to Buy)
A - Award 100,000 100,000
2011-11-03 2011-11-01 4 XYL Xylem Inc.
Stock Option (Right to Buy)
A - Award 250,000 250,000
2011-11-03 2011-11-01 4 XYL Xylem Inc.
Stock Option (Right to Buy)
A - Award 89,235 89,235
2011-11-03 2011-11-01 4 XYL Xylem Inc.
Stock Option (Right to Buy)
A - Award 83,612 83,612
2011-11-03 2011-11-01 4 XYL Xylem Inc.
Stock Option (Right to Buy)
A - Award 199,120 199,120
2011-11-03 2011-11-01 4 XYL Xylem Inc.
Common Stock
A - Award 166,779 232,042 255.55
2011-11-03 3 XYL Xylem Inc.
Common Stock
65,263
2011-11-03 3 XYL Xylem Inc.
Common Stock
50,551
2011-11-03 3 XYL Xylem Inc.
Common Stock
311
2010-03-09 2010-03-05 4 ITT ITT Corp
Employee Stock Option (Right to Buy)
A - Award 132,265 132,265
2010-03-09 2010-03-05 4 ITT ITT Corp
Common Stock
A - Award 41,267 244,633 20.29
2009-11-19 2009-11-17 4 ITT ITT CORP
Phantom Stock
X - Other -8,925 0 -100.00
2009-11-19 2009-11-17 4 ITT ITT CORP
Common Stock
S - Sale -8,925 204,326 -4.19 53.06 -473,560 10,841,538
2009-11-19 2009-11-17 4 ITT ITT CORP
Common Stock
X - Other 8,925 213,251 4.37
2009-11-19 2009-11-17 4 ITT ITT CORP
Common Stock
S - Sale -47,862 204,326 -18.98 53.30 -2,551,045 10,890,576
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)